For Industry - for development in Japan

• Why Japan for drug development (presentation for ENDPOINTS Events)[2.6MB]
  • ENDPOINTS Events on-Demand Session : Developing your new medicine in Japan faster (November 14th, 2024) (external link)​

Note: Registration (free of charge) is required to view the videos.

 

• PMDA’s Support to Venture Companies[2.2MB]
• Doing business in Japan: What is attracting?[1.4MB]
• PMDA’s Activities Leading to Medical Device Innovation[3.2MB]
• Supports from Japanese government (MHLW)(PDF)[1.4MB] (external link)

• Frequently Asked Questions (FAQ)
• PMDA Updates

• Ministry of Health, Labour and Welfare (MHLW) 
  • Medical Innovation Support Office (MEDISO)
• Japan Agency for Medical Research and Development (AMED)
• National Institutes of Biomedical Innovation, Health and Nutrition(NIBIOHN)
  • Orphan Products Development Support Program
• Ministry of Economy, Trade and Industry (METI) 
  • Healthcare Innovation Hub (InnoHub)
• Japan External Trade Organization (JETRO)
• Cabinet Secretarist : Council of the Concept for Early Prevalence of the Novel Drugs to Patients by Improving Drug Discovery Capabilities

• Japan Pharmaceutical Manufacturers Association (JPMA) 
• Pharmaceutical Research and Manufacturers of America (PhRMA)
• European Federation of Pharmaceutical Industries and Associations, Japan (EFPIA Japan) 
• The Japan Federation of Medical Devices Associations (JFMDA)
• American Medical Devices and Diagnostics Manufacturers' Association (AMDD)
• EUROPEAN BUSINESS COUNCIL IN JAPAN (EBC)
• Advanced Medical Technology Association (AdvaMed)
• Forum for Innovative Regenerative Medicine (FIRM)
• Japan CRO Association (JCROA)